Marksans Pharma Limited (NSE:MARKSANS)
222.00
-2.14 (-0.95%)
Mar 28, 2025, 3:30 PM IST
Marksans Pharma Employees
Marksans Pharma had 1,141 employees as of March 31, 2024. The number of employees increased by 289 or 33.92% compared to the previous year.
Employees
1,141
Change (1Y)
289
Growth (1Y)
33.92%
Revenue / Employee
21.69M INR
Profits / Employee
3.23M INR
Market Cap
100.82B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 1,141 | 289 | 33.92% |
Mar 31, 2023 | 852 | -38 | -4.27% |
Mar 31, 2022 | 890 | -248 | -21.79% |
Mar 31, 2021 | 1,138 | -12 | -1.04% |
Mar 31, 2020 | 1,150 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 9,741 |
Cipla | 27,764 |
Mankind Pharma | 19,540 |
Apollo Hospitals Enterprise | 83,147 |
Zydus Lifesciences | 26,921 |
Aurobindo Pharma | 26,015 |
Alkem Laboratories | 17,432 |
Marksans Pharma News
- 11 days ago - Marksans Pharma shares up nearly 4% as company secures Australian TGA approval for Goa facility - Business Upturn
- 11 days ago - Marksans Pharma’s Goa facility gets Australian TGA approval for Solid Dosage manufacturing - Business Upturn
- 12 days ago - Marksans Pharma’s subsidiary Relonchem receives marketing authorization from UK MHRA for Baclofen 10 mg tablets - Business Upturn
- 4 weeks ago - Marksans Pharma’s subsidiary Relonchem gets UK approval for Ibuprofen and Paracetamol tablets - Business Upturn
- 4 months ago - Marksans Pharma shares jump 2% following USFDA approval for Loratadine Tablets USP 10 mg - Business Upturn
- 4 months ago - Marksans Pharma receives USFDA approval for Loratadine Tablets USP 10 mg - Business Upturn
- 4 months ago - Marksans Pharma Ltd (BOM:524404) Q2 FY25 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 4 months ago - Marksans Pharma shares jump over 3% on Q2 results - Business Upturn